Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing. | Emerg Microbes Infect | 2022 | 35899581 | PubTator, text mining | PubMed |
| ILCS: An Improved Lightweight Convolution Structure and Mixed Interactive Attention for Steel Surface Defect Classification. | Comput Intell Neurosci | 2022 | 35898768 | PubTator, text mining | PubMed |
| 1,4-Naphthoquinone (CNN1) Induces Apoptosis through DNA Damage and Promotes Upregulation of H2AFX in Leukemia Multidrug Resistant Cell Line. | Int J Mol Sci | 2022 | 35897681 | PubTator, text mining | PubMed |
| Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. | Sci Transl Med | 2022 | 35895837 | PubTator, text mining | PubMed |
| Traditional Medicinal Uses, Phytochemistry, Biological Properties, and Health Applications of Vitex sp. | Plants (Basel) | 2022 | 35893648 | PubTator, text mining | PubMed |
| Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells. | Cells | 2022 | 35883702 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer. | Clin Cancer Res | 2022 | 35881546 | PubTator, text mining | PubMed |
| Somatic mutation analysis of Mesonephric-Like adenocarcinoma and associated putative precursor Lesions: Insight into pathogenesis and potential molecular treatment targets. | Gynecol Oncol Rep | 2022 | 35880223 | PubTator, text mining | PubMed |
| Effects and Prognostic Values of Circadian Genes CSNK1E/GNA11/KLF9/THRAP3 in Kidney Renal Clear Cell Carcinoma via a Comprehensive Analysis. | Bioengineering (Basel) | 2022 | 35877357 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing for Analyzing the Intestinal Tract in Healthy and Diseased Individuals. | Front Cell Dev Biol | 2022 | 35874838 | PubTator, text mining | PubMed |
| ESG performance and stock prices: evidence from the COVID-19 outbreak in China. | Humanit Soc Sci Commun | 2022 | 35874283 | PubTator, text mining | PubMed |
| Identification of Molecular Targets and Potential Mechanisms of Yinchen Wuling San Against Head and Neck Squamous Cell Carcinoma by Network Pharmacology and Molecular Docking. | Front Genet | 2022 | 35873484 | PubTator, text mining | PubMed |
| Oncogenetic Function and Prognostic Value of DNA Topoisomerase II Alpha in Human Malignances: A Pan-Cancer Analysis. | Front Genet | 2022 | 35873470 | PubTator, text mining | PubMed |
| TDP1-independent pathways in the process and repair of TOP1-induced DNA damage. | Nat Commun | 2022 | 35869071 | PubTator, text mining | PubMed |
| Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021). | Acta Pharm Sin B | 2022 | 35865090 | PubTator, text mining | PubMed |
| DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | Cancer Med | 2022 | 35864588 | PubTator, text mining | PubMed |
| PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib. | Sci Rep | 2022 | 35864202 | PubTator, text mining | PubMed |
| PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1. | Cell Death Dis | 2022 | 35864095 | PubTator, text mining | PubMed |
| Targeting DNA-Protein Crosslinks via Post-Translational Modifications. | Front Mol Biosci | 2022 | 35860355 | PubTator, text mining | PubMed |
| Topotecan Reduces Neuron Death after Spinal Cord Injury by Suppressing Caspase-1-Dependent Pyroptosis. | Mol Neurobiol | 2022 | 35851945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=48